Delivery Order SPE2D018D0006-SPE2D325F5728
Award Date
2/5/25
Potential Completion Date
2/10/25
Potential Value
$5.3K
Federal Agency
Medical Supply Chain
Awardee
Eagle Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westwood, NJ 07677, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract (SPE2D018D0006|SPE2D325F4806) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, for the supply of Ryanodex (250 mg vials), a drug used to treat and prevent malignant hyperthermia. The contract has a ceiling value of $10,585.32 and an ultimate completion date of January 29, 2025. This award is not associated with a set-aside program. Eagle...
This is a federal contract award to Eagle Pharmaceuticals, Inc., a specialized pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Ryanodex, a 250mg injectable medication used for the treatment and prevention of malignant hyperthermia in high-risk patients. The contract award, with a ceiling value of $10,161.24, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 29, 2024. This award is not...
This federal contract award is a delivery order (SPE2D018D0006|SPE2D325F5039) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals"), a for-profit pharmaceutical manufacturer. The contract, valued at $5,292.66, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set-aside and is part of a larger...
This federal contract award, valued at $10,585.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex 250mg vials. Ryanodex is a critical pharmaceutical product used to treat and prevent malignant hyperthermia in high-risk patients. The contract is a delivery order with a firm fixed-price pricing type and a performance period ending on January 29, 2025. This award is not associated with a set-aside designation,...
The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order contract to Eagle Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical products, to provide the drug Ryanodex (250mg vials). The contract has a firm fixed price of $92,838.80 and a period of performance through April 6, 2023. This award is part of Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, which has a...
This federal contract award to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, is a delivery order from the Defense Logistics Agency Troop Support Medical. The contract is for the supply of 250mg vials of the drug Ryanodex, with a firm fixed price of $1,693.54 and a completion date of January 5, 2024. The place of performance is Westwood, New Jersey. This delivery order is part of a larger Federal Supply Schedule contract held by Eagle Pharmaceuticals through the...
The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $9,748.26 firm fixed price delivery order to supply 250 mg vials of the drug Ryanodex. Performance will take place in Westwood, New Jersey over a period of one week from September 15 through September 20, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Department of Defense through the procurement and distribution of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 250 mg vials of the medication Ryanodex. The contract has a ceiling value of $2,979.28 and a period of performance through August 14, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order is for 250 mg vials of the drug Ryanodex, with a ceiling value of $5,716.40. The order was awarded on April 12, 2023 and has a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,283.20, is for the delivery of Ryanodex 250 mg vials, a specialty medication, to support military and government medical programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...